XML 37 R24.htm IDEA: XBRL DOCUMENT
v3.23.1

Note 1 - Nature of Business (Details Textual) | Dec. 31, 2022
--- | ---
Number of Core Drug Technologies | 3
Animal Life Sciences, Inc [Member] |
Equity Method Investment, Ownership Percentage | 10.00%

X
- Definition The number of core drug technologies. + References No definition available. + Details
Name: | mbrx_NumberOfCoreDrugTechnologies
Namespace Prefix: | mbrx_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | instant

X
- Definition The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 323 -SubTopic 10 -Section 50 -Paragraph 3 -Subparagraph (a)(1) -URI https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571 + Details
Name: | us-gaap_EquityMethodInvestmentOwnershipPercentage
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=mbrx_AnimalLifeSciencesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |